Nemaura Medical Inc.
Company Snapshot: Nemaura Medical Inc.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.
- Mar 18 2020 Nemaura To Prepare for Launch of sugarBEAT® CGM In the U.S. Following FDA Feedback
- Mar 10 2020 Nemaura Medical Enters Into Multiple Verbal Non-Binding Agreements for its sugarBEAT® Platform
- Feb 25 2020 Nemaura Medical Plans Head-to-head Study with Major Glucose Monitoring System
- Feb 11 2020 Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019